McGimpsey Stuart J, Woodside Jayne V, Cardwell Chris, Cahill Mark, Chakravarthy Usha
Directorate of Ophthalmology, The Royal Victoria Hospital, The Belfast Health and Social Care Trust, Grosvenor Road, Belfast, Ireland.
Ophthalmology. 2009 Sep;116(9):1778-1787.e1. doi: 10.1016/j.ophtha.2009.02.033.
To assess the role of plasma total homocysteine (tHcy) concentrations and homozygosity for the thermolabile variant of the methylenetetrahydrofolate reductase (MTHFR) C677T gene as risk factors for retinal vascular occlusive disease.
Retinal vein occlusion (RVO) is an important cause of vision loss. Early meta-analyses showed that tHcy was associated with an increased risk of RVO, but a significant number of new studies have been published.
PARTICIPANTS AND/OR CONTROLS: RVO patients and controls.
Data sources included MEDLINE, Web of Science, and PubMed searches and searching reference lists of relevant articles and reviews. Reviewers searched the databases, selected the studies, and then extracted data. Results were pooled quantitatively using meta-analytic methods.
tHcy concentrations and MTHFR genotype.
There were 25 case-control studies for tHcy (1533 cases and 1708 controls) and 18 case-control studies for MTHFR (1082 cases and 4706 controls). The mean tHcy was on average 2.8 micromol/L (95% confidence interval [CI], 1.8-3.7) greater in the RVO cases compared with controls, but there was evidence of between-study heterogeneity (P<0.001, I(2) = 93%). There was funnel plot asymmetry suggesting publication bias. There was no evidence of association between homozygosity for the MTHFR C677T genotype and RVO (odds ratio [OR] 1.20; 95% CI, 0.84-1.71), but again marked heterogeneity (P = 0.004, I(2) = 53%) was observed.
There was some evidence that elevated tHcy was associated with RVO, but not homozygosity for the MTHFR C677T genotype. Both analyses should be interpreted cautiously because of marked heterogeneity between the study estimates and possible effect of publication bias on the tHcy findings.
FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
评估血浆总同型半胱氨酸(tHcy)浓度以及亚甲基四氢叶酸还原酶(MTHFR)C677T基因热不稳定变异型的纯合性作为视网膜血管阻塞性疾病危险因素的作用。
视网膜静脉阻塞(RVO)是视力丧失的重要原因。早期的荟萃分析表明,tHcy与RVO风险增加相关,但已有大量新研究发表。
参与者和/或对照:RVO患者和对照。
数据来源包括MEDLINE、科学网和PubMed搜索以及检索相关文章和综述的参考文献列表。评审人员检索数据库、选择研究,然后提取数据。使用荟萃分析方法对结果进行定量汇总。
tHcy浓度和MTHFR基因型。
有25项关于tHcy的病例对照研究(1533例病例和1708例对照)以及18项关于MTHFR的病例对照研究(1082例病例和4706例对照)。与对照相比,RVO病例的平均tHcy平均高出2.8微摩尔/升(95%置信区间[CI],1.8 - 3.7),但有研究间异质性的证据(P<0.001,I² = 93%)。漏斗图不对称表明存在发表偏倚。没有证据表明MTHFR C677T基因型纯合性与RVO之间存在关联(比值比[OR] 1.20;95% CI,0.84 - 1.71),但同样观察到明显的异质性(P = 0.004,I² = 53%)。
有一些证据表明tHcy升高与RVO相关,但与MTHFR C677T基因型纯合性无关。由于研究估计值之间存在明显异质性以及发表偏倚可能对tHcy研究结果产生影响,这两项分析都应谨慎解释。
作者对本文讨论的任何材料均无所有权或商业利益。